Affluent Medical (France) Top Management

Affluent Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.1607) % which means that it has lost $0.1607 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6251) %, meaning that it generated substantial loss on money invested by shareholders. Affluent Medical's management efficiency ratios could be used to measure how well Affluent Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of February 27, 2026, Return On Tangible Assets is expected to decline to -1.32. In addition to that, Return On Capital Employed is expected to decline to -0.37. At present, Affluent Medical's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 55.5 K, whereas Total Assets are forecasted to decline to about 50.7 M. As of February 27, 2026, Common Stock Shares Outstanding is expected to decline to about 23 M. In addition to that, Net Loss is expected to decline to about (13.9 M)Affluent Medical holds a total of 39.3 Million outstanding shares. Over half of Affluent Medical's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Affluent Medical. Please watch out for any change in the institutional holdings of Affluent Medical SAS as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Affluent Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Affluent Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Affluent Medical Workforce Comparison

The company has Profit Margin (PM) of (2.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (15.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $15.76.

Affluent Medical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Affluent Medical SAS often depends on how effective the management is. Affluent Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Affluent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Affluent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Affluent Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Affluent Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Affluent Medical's management manipulating its earnings.

When running Affluent Medical's price analysis, check to measure Affluent Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affluent Medical is operating at the current time. Most of Affluent Medical's value examination focuses on studying past and present price action to predict the probability of Affluent Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affluent Medical's price. Additionally, you may evaluate how the addition of Affluent Medical to your portfolios can decrease your overall portfolio volatility.